Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.64 USD
Change Today -0.10 / -1.74%
Volume 131.6K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

fibrocell science inc (FCSC) Snapshot

Open
$5.24
Previous Close
$5.74
Day High
$5.80
Day Low
$5.23
52 Week High
08/5/15 - $7.60
52 Week Low
12/15/14 - $2.28
Market Cap
247.5M
Average Volume 10 Days
247.0K
EPS TTM
$-0.61
Shares Outstanding
43.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FIBROCELL SCIENCE INC (FCSC)

fibrocell science inc (FCSC) Related Bloomberg News

View More Bloomberg News

fibrocell science inc (FCSC) Related Businessweek News

No Related Businessweek News Found

fibrocell science inc (FCSC) Details

Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company, through its proprietary autologous fibroblast technology, develops azficel-T, which is in Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring. It is also conducting orphan gene therapy program that is in pre-clinical development stage for the treatment of recessive dystrophic epidermolysis bullosa; and gene therapy program, which is in pre-clinical development stage for linear scleroderma. The company has collaboration agreement with Intrexon Corporation for using genetically-modified autologous fibroblast cells to target proteins in patients with rare genetic skin and connective tissue disorders; and University of California, Los Angeles to focus on discoveries and technologies related to stem cells and regenerative cells in human skin. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was founded in 1995 and is headquartered in Exton, Pennsylvania.

50 Employees
Last Reported Date: 03/13/15
Founded in 1995

fibrocell science inc (FCSC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $490.0K
Controller
Total Annual Compensation: $204.5K
Vice President of Scientific Affairs
Total Annual Compensation: $287.6K
Vice President of Quality
Total Annual Compensation: $148.8K
Compensation as of Fiscal Year 2014.

fibrocell science inc (FCSC) Key Developments

Fibrocell Science, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Fibrocell Science, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company announced total revenue of $137,000 compared to $58,000 for the same period a year ago. Operating loss was $7,359,000 compared to $6,596,000 for the same period a year ago. Loss before income taxes was $6,756,000 compared to $2,257,000 for the same period a year ago. Net loss was $6,756,000 or $0.17 per basic and diluted share compared to $2,257,000 or $0.09 per diluted share for the same period a year ago. Increase in revenue was primarily due to $0.2 million of collaboration revenue recognized in 2015. For the six months, the company announced total revenue of $331,000 compared to $104,000 for the same period a year ago. Operating loss was $14,223,000 compared to $17,596,000 for the same period a year ago. Loss before income taxes was $15,281,000 compared to $16,266,000 for the same period a year ago. Net loss was $15,281,000 or $0.37 per basic and diluted share compared to $16,266,000 or $0.43 per diluted share for the same period a year ago.

Fibrocell Science, Inc. to Report Q2, 2015 Results on Aug 06, 2015

Fibrocell Science, Inc. announced that they will report Q2, 2015 results at 9:00 AM, Eastern Standard Time on Aug 06, 2015

Fibrocell Science, Inc., Q2 2015 Earnings Call, Aug 06, 2015

Fibrocell Science, Inc., Q2 2015 Earnings Call, Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCSC:US $5.64 USD -0.10

FCSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FCSC.
View Industry Companies
 

Industry Analysis

FCSC

Industry Average

Valuation FCSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIBROCELL SCIENCE INC, please visit www.fibrocellscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.